Fonar Free Cash Flow 2010-2024 | FONR
Fonar free cash flow from 2010 to 2024. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
| Fonar Annual Free Cash Flow | |
|---|---|
| 2024 | 13.38 |
| 2023 | 10.25 |
| 2022 | 10.76 |
| 2021 | 15.56 |
| 2020 | 12.88 |
| 2019 | 16.09 |
| 2018 | 15.96 |
| 2017 | 13.96 |
| 2016 | 15.91 |
| 2015 | 13.14 |
| 2014 | 12.77 |
| 2013 | 6.40 |
| 2012 | 6.33 |
| 2011 | 2.55 |
| 2010 | -1.73 |
| 2009 | -6.61 |
| Fonar Quarterly Free Cash Flow | |
|---|---|
| 2024-12-31 | 1.35 |
| 2024-09-30 | -0.15 |
| 2024-06-30 | 13.38 |
| 2024-03-31 | 9.12 |
| 2023-12-31 | 6.50 |
| 2023-09-30 | 2.56 |
| 2023-06-30 | 10.25 |
| 2023-03-31 | 6.60 |
| 2022-12-31 | 4.50 |
| 2022-09-30 | 1.76 |
| 2022-06-30 | 10.76 |
| 2022-03-31 | 6.31 |
| 2021-12-31 | 3.69 |
| 2021-09-30 | 0.06 |
| 2021-06-30 | 15.56 |
| 2021-03-31 | 10.20 |
| 2020-12-31 | 7.41 |
| 2020-09-30 | 3.37 |
| 2020-06-30 | 12.88 |
| 2020-03-31 | 7.33 |
| 2019-12-31 | 5.53 |
| 2019-09-30 | 1.83 |
| 2019-06-30 | 16.09 |
| 2019-03-31 | 10.06 |
| 2018-12-31 | 7.40 |
| 2018-09-30 | 3.32 |
| 2018-06-30 | 15.96 |
| 2018-03-31 | 10.01 |
| 2017-12-31 | 7.02 |
| 2017-09-30 | 3.08 |
| 2017-06-30 | 13.96 |
| 2017-03-31 | 7.65 |
| 2016-12-31 | 5.15 |
| 2016-09-30 | 2.76 |
| 2016-06-30 | 15.91 |
| 2016-03-31 | 9.77 |
| 2015-12-31 | 7.50 |
| 2015-09-30 | 3.42 |
| 2015-06-30 | 13.14 |
| 2015-03-31 | 8.42 |
| 2014-12-31 | 5.86 |
| 2014-09-30 | 2.87 |
| 2014-06-30 | 12.77 |
| 2014-03-31 | 9.00 |
| 2013-12-31 | 6.49 |
| 2013-09-30 | 3.68 |
| 2013-06-30 | 6.40 |
| 2013-03-31 | 5.79 |
| 2012-12-31 | 3.79 |
| 2012-09-30 | 1.42 |
| 2012-06-30 | 6.33 |
| 2012-03-31 | 3.72 |
| 2011-12-31 | 1.90 |
| 2011-09-30 | 0.91 |
| 2011-06-30 | 2.55 |
| 2011-03-31 | 1.25 |
| 2010-12-31 | 1.27 |
| 2010-09-30 | 0.13 |
| 2010-06-30 | -1.73 |
| 2010-03-31 | -1.99 |
| 2009-12-31 | -1.59 |
| 2009-09-30 | 0.29 |
| 2009-06-30 | -6.61 |
| 2009-03-31 | -6.12 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.077B | $0.103B |
| FONAR Corporation is a developer and manufacturer of MRI scanners. The Company has introduced the world's first commercial MRI in 1980, and went public in 1981. FONAR's stellar product is the UPRIGHT MRI, also known as the Stand-Up MRI, the whole-body MRI that performs Position imaging and scans patients in numerous weight-bearing positions like standing, sitting, in flexion and extension, as well as the conventional lie-down position. The Company's subsidiary, Health Management Corporation of America, is a physician practice management company providing management services to medical providers. FONAR Corporation is based in Melville, New York. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $231.816B | 27.87 |
| Boston Scientific (BSX) | United States | $152.176B | 38.10 |
| Stryker (SYK) | United States | $145.393B | 30.40 |
| EssilorLuxottica (ESLOY) | France | $127.544B | 0.00 |
| Medtronic (MDT) | Ireland | $107.067B | 15.63 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.941B | 0.00 |
| Haleon (HLN) | United Kingdom | $48.439B | 27.54 |
| ResMed (RMD) | United States | $35.929B | 26.99 |
| GE HealthCare Technologies (GEHC) | United States | $31.992B | 15.19 |
| Agilent Technologies (A) | United States | $30.486B | 20.14 |
| Terumo (TRUMY) | Japan | $28.205B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $23.066B | 16.58 |
| Insulet (PODD) | United States | $21.859B | 85.82 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.837B | 12.10 |
| Baxter (BAX) | United States | $15.857B | 11.84 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.412B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.030B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.686B | 22.60 |
| Lantheus Holdings (LNTH) | United States | $5.598B | 14.27 |
| Prestige Consumer Healthcare (PBH) | United States | $4.325B | 19.27 |
| Perrigo (PRGO) | Ireland | $3.713B | 9.41 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.426B | 14.92 |
| ICU Medical (ICUI) | United States | $3.404B | 25.10 |
| Envista Holdings (NVST) | United States | $2.981B | 24.77 |
| QuidelOrtho (QDEL) | United States | $2.451B | 16.90 |
| GN Store Nord (GNNDY) | Denmark | $2.075B | 17.19 |
| LeMaitre Vascular (LMAT) | United States | $1.813B | 40.54 |
| AtriCure (ATRC) | United States | $1.534B | 0.00 |
| Neogen (NEOG) | United States | $1.296B | 16.58 |
| Green Thumb Industries (GTBIF) | United States | $1.173B | 26.38 |
| Kestra Medical Technologies (KMTS) | United States | $1.164B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.156B | 11.75 |
| BioLife Solutions (BLFS) | United States | $1.106B | 0.00 |
| InMode (INMD) | Israel | $1.005B | 9.20 |
| Phibro Animal Health (PAHC) | United States | $0.910B | 11.64 |
| Evolus (EOLS) | United States | $0.632B | 0.00 |
| CeriBell (CBLL) | United States | $0.575B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.557B | 0.00 |
| Owens & Minor (OMI) | United States | $0.542B | 4.49 |
| Valneva SE (VALN) | France | $0.541B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.504B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.431B | 0.00 |
| Surmodics (SRDX) | United States | $0.383B | 0.00 |
| Omeros (OMER) | United States | $0.360B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.358B | 0.00 |
| SNDL (SNDL) | Canada | $0.339B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.290B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.288B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.283B | 10.42 |
| Aurora Cannabis (ACB) | Canada | $0.273B | 48.50 |
| Sanuwave Health (SNWV) | United States | $0.257B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.250B | 21.07 |
| Verano Holdings (VRNOF) | United States | $0.248B | 0.00 |
| Cerus (CERS) | United States | $0.247B | 0.00 |
| ZimVie (ZIMV) | United States | $0.244B | 11.09 |
| Canopy Growth (CGC) | Canada | $0.241B | 0.00 |
| Biote (BTMD) | United States | $0.219B | 6.15 |
| Quanterix (QTRX) | United States | $0.205B | 0.00 |
| High Tide (HITI) | Canada | $0.194B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.188B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.176B | 14.18 |
| Brainsway (BWAY) | Israel | $0.164B | 51.24 |
| TriSalus Life Sciences (TLSI) | United States | $0.162B | 0.00 |
| Organigram Global (OGI) | Canada | $0.158B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.147B | 18.16 |
| Jin Medical (ZJYL) | China | $0.130B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.110B | 0.00 |
| Exagen (XGN) | United States | $0.103B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.094B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.092B | 0.00 |
| MacroGenics (MGNX) | United States | $0.090B | 0.00 |
| Agape ATP (ATPC) | $0.078B | 0.00 | |
| Veru (VERU) | United States | $0.074B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.073B | 0.00 |
| InterCure (INCR) | Israel | $0.072B | 0.00 |
| Zynex (ZYXI) | United States | $0.063B | 0.00 |
| United Health Products (UEEC) | United States | $0.059B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.055B | 0.00 |
| ImmuCell (ICCC) | United States | $0.046B | 0.00 |
| Apyx Medical (APYX) | United States | $0.044B | 0.00 |
| Modular Medical (MODD) | United States | $0.041B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.038B | 56.00 |
| United-Guardian (UG) | United States | $0.037B | 12.79 |
| Safety Shot (SHOT) | United States | $0.037B | 0.00 |
| Nephros (NEPH) | United States | $0.020B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.011B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |